Drug companies are now outsourcing research & development to China. Are your medications at risk?
China's biotech industry is booming due to lower costs and fewer regulations. Western firms are taking notice—and moving operations.
Drug development costs average $2.6 billion PER drug! Big Pharma seeks cheaper routes, but at what cost to patients?
Experts warn offshoring drug R&D threatens US national security. "We are losing control of our supply chains," one analyst said.
The FDA struggles to inspect overseas facilities adequately. Imported drugs may bypass rigorous safety checks, putting patients at risk...
A major drug company's internal documents confessed fear about quality. The documents cite 'unacceptable' quality standards, but continue.
Cheaper research means potentially lower quality and less oversight. Are profits being prioritized over patient well being?
Over 80% of active pharmaceutical ingredients come from overseas. This dependence on foreign sources is only increasing!
The US government scrambles to mitigate the risks. Calls grow for reshoring and stricter regulations, but will it be enough?
Will new regulations protect patients or will Big Pharma continue to chase profits abroad? The future remains dangerously uncertain...